6-43780906-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000480614.1(VEGFA):n.6589T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.974 in 1,612,486 control chromosomes in the GnomAD database, including 765,635 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.98 ( 73054 hom., cov: 30)
Exomes 𝑓: 0.97 ( 692581 hom. )
Consequence
VEGFA
ENST00000480614.1 non_coding_transcript_exon
ENST00000480614.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.01
Publications
6 publications found
Genes affected
VEGFA (HGNC:12680): (vascular endothelial growth factor A) This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-43780906-T-C is Benign according to our data. Variant chr6-43780906-T-C is described in ClinVar as Benign. ClinVar VariationId is 1278094.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.986 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VEGFA | NM_003376.6 | c.1034+103T>C | intron_variant | Intron 6 of 7 | ENST00000672860.3 | NP_003367.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VEGFA | ENST00000672860.3 | c.1034+103T>C | intron_variant | Intron 6 of 7 | NM_003376.6 | ENSP00000500082.3 |
Frequencies
GnomAD3 genomes AF: 0.980 AC: 149012AN: 152116Hom.: 72995 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
149012
AN:
152116
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.978 AC: 245080AN: 250640 AF XY: 0.977 show subpopulations
GnomAD2 exomes
AF:
AC:
245080
AN:
250640
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.974 AC: 1422085AN: 1460252Hom.: 692581 Cov.: 45 AF XY: 0.974 AC XY: 707405AN XY: 726446 show subpopulations
GnomAD4 exome
AF:
AC:
1422085
AN:
1460252
Hom.:
Cov.:
45
AF XY:
AC XY:
707405
AN XY:
726446
show subpopulations
African (AFR)
AF:
AC:
33253
AN:
33424
American (AMR)
AF:
AC:
44049
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
24776
AN:
26132
East Asian (EAS)
AF:
AC:
39687
AN:
39700
South Asian (SAS)
AF:
AC:
85271
AN:
86190
European-Finnish (FIN)
AF:
AC:
51785
AN:
53206
Middle Eastern (MID)
AF:
AC:
4575
AN:
4730
European-Non Finnish (NFE)
AF:
AC:
1079981
AN:
1111904
Other (OTH)
AF:
AC:
58708
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2217
4434
6650
8867
11084
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21642
43284
64926
86568
108210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.980 AC: 149130AN: 152234Hom.: 73054 Cov.: 30 AF XY: 0.980 AC XY: 72928AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
149130
AN:
152234
Hom.:
Cov.:
30
AF XY:
AC XY:
72928
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
41298
AN:
41528
American (AMR)
AF:
AC:
14955
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
3301
AN:
3472
East Asian (EAS)
AF:
AC:
5168
AN:
5168
South Asian (SAS)
AF:
AC:
4778
AN:
4824
European-Finnish (FIN)
AF:
AC:
10345
AN:
10606
Middle Eastern (MID)
AF:
AC:
285
AN:
294
European-Non Finnish (NFE)
AF:
AC:
66057
AN:
68026
Other (OTH)
AF:
AC:
2049
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
157
314
470
627
784
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3462
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.